title: [Pantogam active in the complex treatment of dystonic hyperkineses].
abstract: Efficacy of pantogam active in the complex treatment of facial and cervical dystonic hyperkineses was studied in 37 patients (25 women, 12 men) with dystonic torticollis, blepharospasm, oromandibular dystonia with illness duration more than 6 months. In these patients, the previous treatment had no positive effect. Pantogam active was prescribed in dose 900-1800 mg/day during 12 weeks. Efficacy was assessed with the TWSTRS, the HADS and the CGI-I. Pantogam active as add-on to basic treatment led to the reduction of severity in dystonic hyperkineses on the average 2-2,5 months from baseline. The best effect was seen in patients with short disease duration. The prescription of this drug allowed to increase the dose of drugs traditionally used in treatment of dystonia (clonazepam, cyclodole, tiapridal, baclofen) due to the decrease of their side-effects.
authors.forename: E A
authors.initials: EA
authors.lastname: Katunina
authors.forename: E A
authors.initials: EA
authors.lastname: Malykhina
authors.forename: O V
authors.initials: OV
authors.lastname: Avanesova
authors.forename: A A
authors.initials: AA
authors.lastname: Makarova
authors.forename: E K
authors.initials: EK
authors.lastname: Abdurakhmanova
authors.forename: V I
authors.initials: VI
authors.lastname: Gridiakin
mesh_terms: D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005145:Face; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014103:Torticollis / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid